| Methods |
Randomised controlled trial
No mention of blinding
Loss to follow‐up not mentioned |
| Participants |
32 patients undergoing total hip replacement |
| Interventions |
1) 4% Albumin (n = 16)
2) LMW HES (n = 16) |
| Outcomes |
Death (data obtained on contact with study author)
Bleeding
Clotting variables |
| Notes |
Follow‐up 5 postoperative days. Information on allocation concealment was obtained on contact with the study author |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Low risk |
Adequate. Sequentially numbered, sealed, opaque envelopes |
